FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to allergology, and can be applied for treatment of allergic rhinitis of domestic etiology. For this purpose in treatment included is allergen-specific immunotherapy with sublingual introduction of cause-significant allergen. Simultaneously hirudotherapy with application of medical leech on skin in region of oral cavity bottom projection is carried out. Procedures are carried out 2 times per week, starting from 0.1 ml 10-6 degree of dissolving of cause-significant allergen and bringing up to 0.5 ml of undissolved allergen, which after that is introduced 1 time per 2 weeks during 3 years.
EFFECT: invention allows to increase treatment efficiency due to increase of cause-significant allergen penetration into system of organs of mucosal immunity of upper airways.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING MODERATE HOUSE ATOPIC BRONCHIAL ASTHMA IN PATIENTS WITH IMMUNE DEFICIENCY SUFFERING FROM FREQUENT ACUTE RESPIRATORY INFECTIONS | 2013 |
|
RU2533284C1 |
| METHOD OF TREATING ATOPIC DERMATITIS | 2010 |
|
RU2464040C2 |
| METHOD OF TREATING CHRONIC ALLERGIC URTICARIA ACCOMPANYING OPISTHORCHIASIS | 2019 |
|
RU2713152C1 |
| METHOD OF TREATING CHRONIC RECURRENT ALLERGIC DISEASES OF NASAL MUCOSA AND PARANASAL SINUSES BY ENDONASAL AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2411048C1 |
| METHOD FOR PREDICTING ALLERGIC RHINITIS | 2005 |
|
RU2298187C1 |
| METHOD FOR PREVENTING AUTOIMMUNE THYROIDITIS IN THE COURSE OF ALLERGEN-SPECIFIC THERAPY | 2021 |
|
RU2775129C1 |
| METHOD OF SUBLINGUAL ALLERGEN-SPECIFIC IMMUNOTHERAPY (SASI) OF POLLINOSIS WITH HYPOSENSITIZATION AGENT | 2019 |
|
RU2725633C1 |
| METHOD OF TREATING ALLERGIC DISEASES BY AUTOLYMPHOCYTE THERAPY | 2009 |
|
RU2395305C1 |
| METHOD OF TREATING ALLERGIC DISEASES | 2020 |
|
RU2742976C1 |
| METHOD FOR DETERMINING SENSITIZATION TO ALLERGENS | 1998 |
|
RU2153673C2 |
